1
|
Khan H, Jan F, Shakoor A, Khan A, AlAsmari AF, Alasmari F, Ullah S, Al-Harrasi A, Khan M, Ali S. Design, synthesis, molecular docking study, and α-glucosidase inhibitory evaluation of novel hydrazide-hydrazone derivatives of 3,4-dihydroxyphenylacetic acid. Sci Rep 2024; 14:11410. [PMID: 38762658 PMCID: PMC11102520 DOI: 10.1038/s41598-024-62034-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2023] [Accepted: 05/13/2024] [Indexed: 05/20/2024] Open
Abstract
A series of novel Schiff base derivatives (1-28) of 3,4-dihydroxyphenylacetic acid were synthesized in a multi-step reaction. All the synthesized Schiff bases were obtained in high yields and their structures were determined by 1HNMR, 13CNMR, and HR-ESI-MS spectroscopy. Except for compounds 22, 26, 27, and 28, all derivatives show excellent to moderate α-glucosidase inhibition. Compounds 5 (IC50 = 12.84 ± 0.52 µM), 4 (IC50 = 13.64 ± 0.58 µM), 12 (IC50 = 15.73 ± 0.71 µM), 13 (IC50 = 16.62 ± 0.47 µM), 15 (IC50 = 17.40 ± 0.74 µM), 3 (IC50 = 18.45 ± 1.21 µM), 7 (IC50 = 19.68 ± 0.82 µM), and 2 (IC50 = 20.35 ± 1.27 µM) shows outstanding inhibition as compared to standard acarbose (IC50 = 873.34 ± 1.67 µM). Furthermore, a docking study was performed to find out the interaction between the enzyme and the most active compounds. With this research work, 3,4-dihydroxyphenylacetic acid Schiff base derivatives have been introduced as a potential class of α-glucosidase inhibitors that have remained elusive till now.
Collapse
Affiliation(s)
- Hammad Khan
- Organic Synthesis and Catalysis Research Laboratory, Institute of Chemical Sciences, University of Peshawar, Peshawar, 25120, Khyber Pakhtunkhwa, Pakistan
| | - Faheem Jan
- Shenyang National Laboratory for Materials Science, Institute of Metal Research Chinese Academy of Sciences, Shenyang, 110016, Liaoning, China
- School of Materials Science and Engineering, University of Science and Technology of China, Shenyang, 110016, Liaoning, China
| | - Abdul Shakoor
- Department of Chemistry, Abdul Wali Khan University, Mardan, 23200, Pakistan
| | - Ajmal Khan
- Natural and Medical Sciences Research Center, University of Nizwa, PO Box 33, 616, Birkat Al Mauz, Nizwa, Oman
| | - Abdullah F AlAsmari
- Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia
| | - Fawaz Alasmari
- Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia
| | - Saeed Ullah
- Natural and Medical Sciences Research Center, University of Nizwa, PO Box 33, 616, Birkat Al Mauz, Nizwa, Oman
| | - Ahmed Al-Harrasi
- Natural and Medical Sciences Research Center, University of Nizwa, PO Box 33, 616, Birkat Al Mauz, Nizwa, Oman.
| | - Momin Khan
- Department of Chemistry, Abdul Wali Khan University, Mardan, 23200, Pakistan.
| | - Shaukat Ali
- Organic Synthesis and Catalysis Research Laboratory, Institute of Chemical Sciences, University of Peshawar, Peshawar, 25120, Khyber Pakhtunkhwa, Pakistan.
| |
Collapse
|
2
|
Soni A, Kumar A, Kumar V, Rawat R, Eyupoglu V. Design, synthesis and evaluation of aminothiazole derivatives as potential anti-Alzheimer's candidates. Future Med Chem 2024; 16:513-529. [PMID: 38375588 DOI: 10.4155/fmc-2023-0290] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2023] [Accepted: 01/26/2024] [Indexed: 02/21/2024] Open
Abstract
Aim: The objective of the present study was to design, synthesize and evaluate diverse Schiff bases and thiazolidin-4-one derivatives of aminothiazole as key pharmacophores possessing acetylcholinesterase inhibitory activity. Materials & methods: Two series of compounds (13 each) were synthesized and evaluated for their acetylcholinesterase inhibition and antioxidant activity. Molecular docking of all compounds was performed to provide an insight into their binding interactions. Results: Compounds 2j (IC50 = 0.03 μM) and 3e (IC50 = 1.58 μM) were found to be the best acetylcholinesterase inhibitors among compounds of their respective series. Molecular docking analysis supported the results of in vitro activity by displaying good docking scores with the binding pocket of human acetylcholinesterase (Protein Data Bank ID: 4EY7). Conclusion: Compound 2j emerged as a potential lead compound with excellent acetylcholinesterase inhibition, antioxidant and chelation activity.
Collapse
Affiliation(s)
- Arti Soni
- Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science & Technology, Hisar, 125001, Haryana, India
| | - Ashwani Kumar
- Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science & Technology, Hisar, 125001, Haryana, India
| | - Vivek Kumar
- Janta College of Pharmacy, Butana, (Sonipat), 131001, Haryana, India
| | - Ravi Rawat
- School of Health Sciences & Technology, UPES University, Dehradun, 248007, India
| | - Volkan Eyupoglu
- Department of Chemistry, Cankırı Karatekin University, Cankırı, 18100, Turkey
| |
Collapse
|
3
|
Abdollahi Z, Nejabat M, Abnous K, Hadizadeh F. The therapeutic value of thiazole and thiazolidine derivatives in Alzheimer's disease: a systematic literature review. Res Pharm Sci 2024; 19:1-12. [PMID: 39006977 PMCID: PMC11244712 DOI: 10.4103/1735-5362.394816] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2022] [Revised: 04/19/2023] [Accepted: 12/23/2023] [Indexed: 07/16/2024] Open
Abstract
Background and purpose Alzheimer's disease (AD) is a common neurodegenerative disease and the fifth leading cause of death among the elderly. The development of drugs for AD treatment is based on inhibiting cholinesterase (ChE) activity and inhibiting amyloid-beta peptide and tau protein aggregations. Many in vitro findings have demonstrated that thiazole-and thiazolidine-based compounds have a good inhibitory effect on ChE and other elements involved in the AD pathogenicity cascade. Experimental approach In the present review, we collected available documents to verify whether these synthetic compounds can be a step forward in developing new medications for AD. A systematic literature search was performed in major electronic databases in April 2021. Twenty-eight relevant in vitro and in vivo studies were found and used for data extraction. Findings/Results Findings demonstrated that thiazole-and thiazolidine-based compounds could ameliorate AD's pathologic condition by affecting various targets, including inhibition of ChE activity, amyloid-beta, and tau aggregation in addition to cyclin-dependent kinase 5/p25, beta-secretase-1, cyclooxygenase, and glycogen synthase kinase-3β. Conclusion and implications Due to multitarget effects at micromolar concentration, this review demonstrated that these synthetic compounds could be considered promising candidates for developing anti-Alzheimer drugs.
Collapse
Affiliation(s)
- Zahra Abdollahi
- Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Mojgan Nejabat
- Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Khalil Abnous
- Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Farzin Hadizadeh
- Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
- Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
| |
Collapse
|
4
|
Puentes-Díaz N, Chaparro D, Reyes-Marquez V, Morales-Morales D, Flores-Gaspar A, Alí-Torres J. Computational Evaluation of the Potential Pharmacological Activity of Salen-Type Ligands in Alzheimer's Disease. J Alzheimers Dis 2024; 99:S383-S396. [PMID: 37483007 DOI: 10.3233/jad-230542] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/25/2023]
Abstract
Background Alzheimer's disease (AD) is the most common form of dementia representing from 60% to 70% of the cases globally. It is a multifactorial disease that, among its many pathological characteristics, has been found to provoke the metal ion dysregulation in the brain, along with an increase in the oxidative stress. There is proof that metallic complexes formed by the amyloid-β peptide (Aβ) and extraneuronal copper can catalyze the production of reactive oxygen species, leading to an increase in oxidative stress, promoting neuronal death. Due to this interaction, bioavailable copper has become an important redox active target to consider within the search protocols of multifunctional agents for AD's treatment. Objective In this study, we examined by using bioinformatics and electronic structure calculations the potential application of 44 salen-type copper chelating ligands and 12 further proposed molecules as possible multifunctional agents in the context of AD. Methods The candidates were evaluated by combining bioinformatic tools and electronic structure calculations, which allowed us to classify the molecules as potential antioxidants, redistributor-like compounds, and the newly proposed suppressor mechanism. Results This evaluation demonstrate that salen-type ligands exhibit properties suitable for interfering in the chain of copper-induced oxidative stress reactions present in AD and potential redistributor and suppressor activity for copper ions. Finally, a novel set of plausible candidates is proposed and evaluated. Conclusion According to the evaluated criteria, a subset of 13 salen-type candidates was found to exhibit promissory pharmacological properties in the AD framework and were classified according to three plausible action mechanisms.
Collapse
Affiliation(s)
- Nicolás Puentes-Díaz
- Departamento de Química, Universidad Nacionalde Colombia -Sede Bogotá, Bogotá, Colombia
| | - Diego Chaparro
- Departamento de Química, Universidad Nacionalde Colombia -Sede Bogotá, Bogotá, Colombia
- Departamento de Química, Universidad Militar Nueva Granada, Cajicá, Colombia
| | - Viviana Reyes-Marquez
- Departamentode Ciencias Químico-Biológicas, Universidad de Sonora, Luis Encinas y Rosales S/N, Hermosillo, México
| | - David Morales-Morales
- Instituto de Química, Universidad Nacional Autónoma de México, Circuito Exterior, Ciudad Universitaria, Ciudad de México, México
| | - Areli Flores-Gaspar
- Departamento de Química, Universidad Militar Nueva Granada, Cajicá, Colombia
| | - Jorge Alí-Torres
- Departamento de Química, Universidad Nacionalde Colombia -Sede Bogotá, Bogotá, Colombia
| |
Collapse
|
5
|
Inhibition of Cholinesterases by Benzothiazolone Derivatives. Processes (Basel) 2022. [DOI: 10.3390/pr10091872] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Thirteen benzothiazolone derivatives (M1–M13) were synthesized and evaluated for their inhibitory activity against cholinesterases (ChEs) and monoamine oxidases (MAOs). All the compounds inhibited ChEs more effectively than MAOs. In addition, most of the compounds showed higher inhibitory activities against butyrylcholinesterase (BChE) than acetylcholinesterase (AChE). Compound M13 most potently inhibited BChE with an IC50 value of 1.21 μM, followed by M2 (IC50 = 1.38 μM). Compound M2 had a higher selectivity index (SI) value for BChE over AChE (28.99) than M13 (4.16). The 6-methoxy indole group of M13 was expected to have a greater effect on BChE inhibitory activity than the other groups. Kinetics and reversibility tests showed that M13 was a reversible noncompetitive BChE inhibitor with a Ki value of 1.14 ± 0.21 μM. In a docking simulation, M13 is predicted to form a hydrogen bond with the backbone carbonyl group of Ser287 of BChE through its methoxy indole moiety and π−π interactions between its benzothiazolone group and the side chain of Trp82 with the five-membered pyrrole ring and with the six-membered benzene ring. From these results, it is suggested that M13 is a BChE inhibitor and a potential candidate agent for the treatment of Alzheimer’s disease.
Collapse
|
6
|
Hosseini Nasab N, Azimian F, Kruger HG, Kim SJ. 3‐Bromoacetylcoumarin, a Crucial Key for Facial Synthesis of Biological Active Compounds. ChemistrySelect 2022. [DOI: 10.1002/slct.202201734] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Narges Hosseini Nasab
- Department of Biological Sciences Kongju National University Gongju, Chungnam 32588, Republic of Korea
| | - Fereshteh Azimian
- Department of Medicinal Chemistry School of Pharmacy Tabriz University of Medical Sciences Tabriz Iran
- Biotechnology Research Center Tabriz University of Medical Sciences Tabriz Iran
| | - Hendrik G. Kruger
- Catalysis and Peptide Research Unit School of Health Sciences University of KwaZulu-Natal Durban 4001 South Africa
| | - Song Ja Kim
- Department of Biological Sciences Kongju National University Gongju, Chungnam 32588, Republic of Korea
| |
Collapse
|
7
|
Yıldız M, Bingul M, Zorlu Y, Saglam MF, Boga M, Temel M, Koca MS, Kandemir H, Sengul IF. Dimethoxyindoles based thiosemicarbazones as multi-target agents; synthesis, crystal interactions, biological activity and molecular modeling. Bioorg Chem 2022; 120:105647. [PMID: 35121556 DOI: 10.1016/j.bioorg.2022.105647] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2021] [Revised: 01/05/2022] [Accepted: 01/25/2022] [Indexed: 01/14/2023]
Abstract
Alzheimer's disease (AD) is known as one of the most devastating neurodegenerative disease diagnosed for the old-aged people and cholinesterase inhibitors (ChEI) can be used as an effective palliative treatment for AD. A range of novel monomeric and dimeric indole based thiosemicarbazone derivatives 17-28 was synthesized in order to target cholinesterases (ChE). Biological importance of the targeted compounds 17-28 was investigated by employing the acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzymes along with three different antioxidant property determination assays, namely DPPH free radical scavenging, ABTS cationic radical decolarization, and CUPRAC cupric reducing antioxidant capacity. The compounds 18 and 19 displayed the best inhibitor activity against BChE with IC50 values of 7.42 and 1.95 μM, respectively. The antioxidant potentials were found to be moderate for DPPH and ABTS assays and the compounds 28 and 18 were the most potent candidates for both antioxidant assays. Cupric reducing capacity was the most promising assay and the compounds 25, 26 and 28 provided better inhibition values than all the standards. Further binding mode and affinity studies performed by molecular docking and molecular dynamics simulations. Accordingly, the compound 19 is the most plausible candidate that can compete with galantamine (GNT), a common pharmaceutics targeting both cholinesterase enzymes.
Collapse
Affiliation(s)
- Minhal Yıldız
- Department of Chemistry, Faculty of Art and Science, Tekirdag Namık Kemal University, Turkey
| | - Murat Bingul
- Department of Basic Pharmaceutical Chemistry, Faculty of Pharmacy, Dicle University, Diyarbakır 21280, Turkey
| | - Yunus Zorlu
- Department of Chemistry, Faculty of Science, Gebze Technical University, Kocaeli, Turkey
| | - Mehmet F Saglam
- Department of Chemistry, Faculty of Science, Gebze Technical University, Kocaeli, Turkey
| | - Mehmet Boga
- Department of Analytical Chemistry, Faculty of Pharmacy, Dicle University, Diyarbakır 21280, Turkey
| | - Mutesir Temel
- Department of Chemistry, Faculty of Science, Gebze Technical University, Kocaeli, Turkey
| | - Mehmet Serdar Koca
- Department of Molecular Biology and Genetics, Faculty of Science, Gebze Technical University, Kocaeli, Turkey
| | - Hakan Kandemir
- Department of Chemistry, Faculty of Art and Science, Tekirdag Namık Kemal University, Turkey
| | - Ibrahim F Sengul
- Department of Chemistry, Faculty of Science, Gebze Technical University, Kocaeli, Turkey.
| |
Collapse
|
8
|
Abdou MM, Abu-Rayyan A, Bedir AG, Abdel-Fattah S, Omar AMA, Ahmed AA, El-Desoky ESI, Ghaith EA. 3-(Bromoacetyl)coumarins: unraveling their synthesis, chemistry, and applications. RSC Adv 2021; 11:38391-38433. [PMID: 35493203 PMCID: PMC9044231 DOI: 10.1039/d1ra05574g] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2021] [Accepted: 10/21/2021] [Indexed: 12/17/2022] Open
Abstract
This review emphasizes recent developments in synthetic routes of 3-(bromoacetyl)coumarin derivatives. Also, chemical reactions of 3-(bromoacetyl)coumarins as versatile building blocks in the preparation of critical polyfunctionalized heterocyclic systems and other industrially significant scaffolds are described. Recent advances of 3-(bromoacetyl)coumarins as attractive starting points towards a wide scale of five and six-membered heterocyclic systems such as thiophenes, imidazoles, pyrazoles, thiazoles, triazoles, pyrans, pyridines, thiadiazins as well as fused heterocyclic systems have been reported. Additionally, this review covers a wide range of analytical chemistry, fluorescent sensors, and biological applications of these moieties, covering the literature till May 2021.
Collapse
Affiliation(s)
- Moaz M Abdou
- Egyptian Petroleum Research Institute Nasr City Cairo 11727 Egypt
| | - Ahmed Abu-Rayyan
- Faculty of Science, Applied Science Private University P. O. BOX 166 Amman 11931 Jordan
| | - Ahmed G Bedir
- Egyptian Petroleum Research Institute Nasr City Cairo 11727 Egypt
| | - S Abdel-Fattah
- Egyptian Petroleum Research Institute Nasr City Cairo 11727 Egypt
| | - A M A Omar
- Egyptian Petroleum Research Institute Nasr City Cairo 11727 Egypt
| | - Abdullah A Ahmed
- Department of Chemistry, Faculty of Science, Al-Azhar University Cairo 11884 Egypt
| | - El-Sayed I El-Desoky
- Department of Chemistry, Faculty of Science, Mansoura University Mansoura 35516 Egypt
| | - Eslam A Ghaith
- Department of Chemistry, Faculty of Science, Mansoura University Mansoura 35516 Egypt
| |
Collapse
|
9
|
Husain A, Balushi K A, Akhtar MJ, Khan SA. Coumarin linked heterocyclic hybrids: A promising approach to develop multi target drugs for Alzheimer's disease. J Mol Struct 2021. [DOI: 10.1016/j.molstruc.2021.130618] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
10
|
Bhujbal N, Gaikwad D, Jagdale Y, Pawar C. Synthesis, antimicrobial and anti‐tubercular activity study of N‐(substituted‐benzyl)‐4‐(trifluoromethyl)thiazole‐2‐sulfonamide and 2‐(N‐(substituted‐benzyl)sulfamoyl)thiazole‐4‐carboxylic acid. J CHIN CHEM SOC-TAIP 2021. [DOI: 10.1002/jccs.202000421] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Namdeo Bhujbal
- Department of Chemistry, Chemistry Research Centre Annasaheb Magar Mahavidyalaya, Hadapsar Pune Maharashtra India
| | - Dattatray Gaikwad
- Department of Chemistry Deogiri College Aurangabad Maharashtra India
| | - Yuvraj Jagdale
- Department of Chemistry, Chemistry Research Centre Annasaheb Magar Mahavidyalaya, Hadapsar Pune Maharashtra India
| | - Chandrakant Pawar
- Department of Chemical Technology Dr. Babasaheb Ambedkar Marathwada University Aurangabad Maharashtra India
- Department of Pharmaceutical Chemistry, Discipline of Pharmaceutical Sciences, College of Health Sciences University of KwaZulu‐Natal Westville Campus, Durban South Africa
| |
Collapse
|
11
|
Amin KM, Abdel Rahman DE, Abdelrasheed Allam H, El-Zoheiry HH. Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer's disease. Bioorg Chem 2021; 110:104792. [PMID: 33799178 DOI: 10.1016/j.bioorg.2021.104792] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2020] [Revised: 02/23/2021] [Accepted: 03/02/2021] [Indexed: 12/11/2022]
Abstract
Twenty novel 7-benzyloxycoumarin based compounds were synthesized with a variety of bioactive chemical fragments. The synthesized compounds showed remarkable acetylcholinesterase (AChE) inhibitory activity. In vitro assay revealed that compounds 7-benzyloxy-4-{[(4-phenylthiazol-2(3H)-ylidene)hydrazono]methyl}-2H-chromen-2-one (5b, IC50= 0.451μM), 7-benzyloxy-4-({[4-(4-methoxyphenyl)thiazol-2(3H)-ylidene]hydrazono}methyl)-2H-chromen-2-one (5d, IC50= 0.625μM), 5-amino-1-[2-(7-benzyloxy-2-oxo-2H-chromen-4-yl)acetyl]-1H-pyrazole-4-carbonitrile (13c, IC50= 0.466μM), 2-(7-benzyloxy-2-oxo-2H-chromen-4-yl)-N-(2-methylimino-4-phenylthiazol-3(2H)-yl)acetamide (16a, IC50= 0.500μM) and 2-(7-benzyloxy-2-oxo-2H-chromen-4-yl)-N-[4-(4-methoxyphenyl)-2-methyliminothiazol-3(2H)-yl]acetamide (16b, IC50= 0.590μM) exhibited promising AChE inhibitory activity even better than donepezil (IC50= 0.711μM). Kinetic study for compound 5b implied mixed type inhibitor which could bind peripheral anionic site (PAS) and catalytic active site (CAS) of AChE enzyme. In addition, in vivo evaluation of compounds 5b, 13c and 16a confirmed significant memory improvement in scopolamine-induced impairment model in tested mice. Furthermore, in silico studies were performed on the synthesized compounds which included molecular docking study at the active site of recombinant human acetylcholinesterase enzyme (rhAChE) as well as prediction of ADMET and other physicochemical parameters. A correlation between the docking results and IC50 of tested compounds was routinely observed and shared similar binding pattern to the co-crystallized ligand donepezil.
Collapse
Affiliation(s)
- Kamilia M Amin
- Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini St., Cairo 11562, Egypt
| | - Doaa E Abdel Rahman
- Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini St., Cairo 11562, Egypt
| | - Heba Abdelrasheed Allam
- Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini St., Cairo 11562, Egypt
| | - Haidy H El-Zoheiry
- Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini St., Cairo 11562, Egypt.
| |
Collapse
|
12
|
Facile one-pot synthesis, butyrylcholinesterase and α-glucosidase inhibitory activities, structure–activity relationship, molecular docking and DNA–drug binding analysis of Meldrum’s acid derivatives. RESEARCH ON CHEMICAL INTERMEDIATES 2020. [DOI: 10.1007/s11164-020-04100-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
13
|
Yusefi S, Akhbari K, White J, Phuruangrat A. Conversion of kinetically stable metal-organic product to thermodynamically stable one approved by thermal treatment and sonochemical reaction. J Mol Struct 2020. [DOI: 10.1016/j.molstruc.2019.127443] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
14
|
Zhou S, Yuan Y, Zheng F, Zhan CG. Structure-based virtual screening leading to discovery of highly selective butyrylcholinesterase inhibitors with solanaceous alkaloid scaffolds. Chem Biol Interact 2019; 308:372-376. [PMID: 31152736 PMCID: PMC6613991 DOI: 10.1016/j.cbi.2019.05.051] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2019] [Revised: 05/08/2019] [Accepted: 05/29/2019] [Indexed: 11/29/2022]
Abstract
According to recent research advance, it is interesting to identify new, potent and selective inhibitors of human butyrylcholinesterase (BChE) for therapeutic treatment of both the Alzheimer's disease (AD) and heroin abuse. In this study, we carried out a structure-based virtual screening followed by in vitro activity assays, with the goal to identify new inhibitors that are selective for BChE over acetylcholinesterase (AChE). As a result, a set of new, selective inhibitors of human BChE were identified from natural products with solanaceous alkaloid scaffolds. The most active one of the natural products (compound 1) identified has an IC50 of 16.8 nM against BChE. It has been demonstrated that the desirable selectivity of these inhibitors for BChE over AChE is mainly controlled by three key residues in the active site cavity, i.e. residues Q119, A277, and A328 in BChE versus the respective residues Y124, W286, and Y337 in AChE. Based on this structural insight, future rational design of new, potent and selective BChE inhibitors may focus on these key structural differences in the active site cavity.
Collapse
Affiliation(s)
- Shuo Zhou
- Molecular Modeling and Biopharmaceutical Center, 789 South Limestone Street, Lexington, KY, 40536, USA; Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 789 South Limestone Street, Lexington, KY, 40536, USA
| | - Yaxia Yuan
- Molecular Modeling and Biopharmaceutical Center, 789 South Limestone Street, Lexington, KY, 40536, USA; Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 789 South Limestone Street, Lexington, KY, 40536, USA
| | - Fang Zheng
- Molecular Modeling and Biopharmaceutical Center, 789 South Limestone Street, Lexington, KY, 40536, USA; Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 789 South Limestone Street, Lexington, KY, 40536, USA.
| | - Chang-Guo Zhan
- Molecular Modeling and Biopharmaceutical Center, 789 South Limestone Street, Lexington, KY, 40536, USA; Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 789 South Limestone Street, Lexington, KY, 40536, USA.
| |
Collapse
|
15
|
Wang L, Wu YR, Ren ST, Yin L, Liu XJ, Cheng FC, Liu WW, Shi DH, Cao ZL, Sun HM. Synthesis and bioactivity of novel C2-glycosyl oxadiazole derivatives as acetylcholinesterase inhibitors. HETEROCYCL COMMUN 2018. [DOI: 10.1515/hc-2018-0166] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
A series of glycosyl-substituted 1,3,4-oxadiazoles were synthesized by cyclization of glycosyl-acylthiosemicarbazides via a base-catalyzed reaction. The starting glycosyl-acylthiosemicarbazide derivatives were obtained by the reaction of glycosyl isothiocyanate with various hydrazides. The acetylcholinesterase (AChE) inhibitory activities of the products were tested by Ellman’s method. The most active compounds were subsequently evaluated for the 50% inhibitory concentration (IC50) values. N-(1,3,4,6-tetra-O-benzyl-2-deoxy-β-D-glucopyranosyl)-5-(4-fluorophenyl)-1,3,4-oxadiazole-2-amine (6i) possesses the best AChE -inhibition activity with an IC50 of 1.61±0.34 μm.
Collapse
|
16
|
Larik FA, Saeed A, Channar PA, Muqadar U, Abbas Q, Hassan M, Seo SY, Bolte M. Design, synthesis, kinetic mechanism and molecular docking studies of novel 1-pentanoyl-3-arylthioureas as inhibitors of mushroom tyrosinase and free radical scavengers. Eur J Med Chem 2017; 141:273-281. [DOI: 10.1016/j.ejmech.2017.09.059] [Citation(s) in RCA: 55] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2016] [Revised: 09/25/2017] [Accepted: 09/27/2017] [Indexed: 12/24/2022]
|
17
|
Zhang WG, Liang JH. Microwave-assisted synthesis, crystal structures, and in vitro antibacterial studies of zinc(II) and nickel(II) complexes with Schiff bases. RUSS J COORD CHEM+ 2017. [DOI: 10.1134/s1070328417080085] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
18
|
Dual Inhibition of AChE and BChE with the C-5 Substituted Derivative of Meldrum’s Acid: Synthesis, Structure Elucidation, and Molecular Docking Studies. CRYSTALS 2017. [DOI: 10.3390/cryst7070211] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
|
19
|
Symmetrical aryl linked bis-iminothiazolidinones as new chemical entities for the inhibition of monoamine oxidases: Synthesis, in vitro biological evaluation and molecular modelling analysis. Bioorg Chem 2017; 70:17-26. [DOI: 10.1016/j.bioorg.2016.11.004] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2016] [Revised: 10/17/2016] [Accepted: 11/06/2016] [Indexed: 01/18/2023]
|
20
|
Murtaza S, Abbas A, Iftikhar K, Shamim S, Akhtar MS, Razzaq Z, Naseem K, Elgorban AM. Synthesis, biological activities and docking studies of novel 2,4-dihydroxybenzaldehyde based Schiff base. Med Chem Res 2016. [DOI: 10.1007/s00044-016-1711-y] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
|
21
|
Coumarins as cholinesterase inhibitors: A review. Chem Biol Interact 2016; 254:11-23. [DOI: 10.1016/j.cbi.2016.05.001] [Citation(s) in RCA: 105] [Impact Index Per Article: 13.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2015] [Revised: 04/14/2016] [Accepted: 05/01/2016] [Indexed: 11/22/2022]
|
22
|
Bondock S, Albormani O, Fouda AM, Abu Safieh KA. Progress in the chemistry of 5-acetylthiazoles. SYNTHETIC COMMUN 2016. [DOI: 10.1080/00397911.2016.1180700] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Affiliation(s)
- Samir Bondock
- Chemistry Department, Faculty of Science, King Khalid University, Abha, Saudi Arabia
- Chemistry Department, Faculty of Science, Mansoura University, Mansoura, Egypt
| | - Omeer Albormani
- Chemistry Department, Faculty of Science, King Khalid University, Abha, Saudi Arabia
| | - Ahmed M. Fouda
- Chemistry Department, Faculty of Science, King Khalid University, Abha, Saudi Arabia
| | - Kayed A. Abu Safieh
- Chemistry Department, Faculty of Science, King Khalid University, Abha, Saudi Arabia
| |
Collapse
|
23
|
Cui LY, Wang YM, Zhou ZH. Enantioselective construction of novel chiral spirooxindoles incorporating a thiazole nucleus. RSC Adv 2016. [DOI: 10.1039/c6ra14178a] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Enantioselective synthesis of novel thiazole-fused spirooxindoles has been realized via chiral thiourea catalyzed asymmetric cascade Michael addition/cyclization of thiazolones and 3-ylideneoxindoles.
Collapse
Affiliation(s)
- L.-Y. Cui
- Institute and State Key Laboratory of Elemento-Organic Chemistry
- Nankai University
- Tianjin 300071
- P. R. China
| | - Y.-M. Wang
- Institute and State Key Laboratory of Elemento-Organic Chemistry
- Nankai University
- Tianjin 300071
- P. R. China
| | - Z.-H. Zhou
- Institute and State Key Laboratory of Elemento-Organic Chemistry
- Nankai University
- Tianjin 300071
- P. R. China
- Collaborative Innovation Center of Chemical Science and Engineering (Tianjin)
| |
Collapse
|
24
|
Saeed A, Zaib S, Ashraf S, Iftikhar J, Muddassar M, Zhang KYJ, Iqbal J. Synthesis, cholinesterase inhibition and molecular modelling studies of coumarin linked thiourea derivatives. Bioorg Chem 2015; 63:58-63. [PMID: 26440714 DOI: 10.1016/j.bioorg.2015.09.009] [Citation(s) in RCA: 40] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2015] [Revised: 09/14/2015] [Accepted: 09/28/2015] [Indexed: 12/27/2022]
Abstract
Alzheimer's disease is among the most widespread neurodegenerative disorder. Cholinesterases (ChEs) play an indispensable role in the control of cholinergic transmission and thus the acetylcholine level in the brain is enhanced by inhibition of ChEs. Coumarin linked thiourea derivatives were designed, synthesized and evaluated biologically in order to determine their inhibitory activity against acetylcholinesterases (AChE) and butyrylcholinesterases (BChE). The synthesized derivatives of coumarin linked thiourea compounds showed potential inhibitory activity against AChE and BChE. Among all the synthesized compounds, 1-(2-Oxo-2H-chromene-3-carbonyl)-3-(3-chlorophenyl)thiourea (2e) was the most potent inhibitor against AChE with an IC50 value of 0.04±0.01μM, while 1-(2-Oxo-2H-chromene-3-carbonyl)-3-(2-methoxyphenyl)thiourea (2b) showed the most potent inhibitory activity with an IC50 value of 0.06±0.02μM against BChE. Molecular docking simulations were performed using the homology models of both cholinesterases in order to explore the probable binding modes of inhibitors. Results showed that the novel synthesized coumarin linked thiourea derivatives are potential candidates to develop for potent and efficacious acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitors.
Collapse
Affiliation(s)
- Aamer Saeed
- Department of Chemistry, Quaid-I-Azam University, Islamabad, Pakistan
| | - Sumera Zaib
- Centre for Advanced Drug Research, COMSATS Institute of Information Technology, Abbottabad 22060, Pakistan
| | - Saba Ashraf
- Department of Chemistry, Quaid-I-Azam University, Islamabad, Pakistan
| | - Javeria Iftikhar
- Centre for Advanced Drug Research, COMSATS Institute of Information Technology, Abbottabad 22060, Pakistan
| | - Muhammad Muddassar
- Structural Bioinformatics Team, Division of Structural and Synthetic Biology, Center for Life Science Technologies, RIKEN, 1-7-22 Suehiro, Yokohama, Kanagawa 230-0045, Japan; Department of Biosciences, COMSATS Institute of Information Technology, Park Road, Islamabad, Pakistan
| | - Kam Y J Zhang
- Structural Bioinformatics Team, Division of Structural and Synthetic Biology, Center for Life Science Technologies, RIKEN, 1-7-22 Suehiro, Yokohama, Kanagawa 230-0045, Japan
| | - Jamshed Iqbal
- Centre for Advanced Drug Research, COMSATS Institute of Information Technology, Abbottabad 22060, Pakistan.
| |
Collapse
|
25
|
Moon SH, Latif M, Qasim M, Choi SW, Lee JY, Byun BJ, Saeed A, Kim SH. Synthesis, Characterization, and Biological Evaluation of Oxadiazole Derivatives Bearing 5-Phenyl-tetrazole as Osteoclast Differentiation Inhibitors. B KOREAN CHEM SOC 2015. [DOI: 10.1002/bkcs.10436] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Seong-Hee Moon
- Laboratory of Translational Therapeutics; Korea Research Institute of Chemical Technology; Daejeon 305-600 Republic of Korea
| | - Muhammad Latif
- Center for Catalytic Hydrocarbon Functionalization; Institute for Basic Science (IBS) and Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST); Daejeon 305-701 Korea
| | - Muhammad Qasim
- Department of Chemistry; Quaid-I-Azam University; Islamabad 45320 Pakistan
| | - Sik-Won Choi
- Laboratory of Translational Therapeutics; Korea Research Institute of Chemical Technology; Daejeon 305-600 Republic of Korea
| | - Joo Yun Lee
- Drug Discovery Platform Technology Group; Korea Research Institute of Chemical Technology; Daejeon 305-600 Republic of Korea
| | - Byung Jin Byun
- Drug Discovery Platform Technology Group; Korea Research Institute of Chemical Technology; Daejeon 305-600 Republic of Korea
| | - Aamer Saeed
- Department of Chemistry; Quaid-I-Azam University; Islamabad 45320 Pakistan
| | - Seong Hwan Kim
- Laboratory of Translational Therapeutics; Korea Research Institute of Chemical Technology; Daejeon 305-600 Republic of Korea
| |
Collapse
|
26
|
Ayati A, Emami S, Asadipour A, Shafiee A, Foroumadi A. Recent applications of 1,3-thiazole core structure in the identification of new lead compounds and drug discovery. Eur J Med Chem 2015; 97:699-718. [PMID: 25934508 DOI: 10.1016/j.ejmech.2015.04.015] [Citation(s) in RCA: 254] [Impact Index Per Article: 28.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2014] [Revised: 10/26/2014] [Accepted: 04/06/2015] [Indexed: 02/07/2023]
Abstract
1,3-Thiazole is one of the most important scaffolds in heterocyclic chemistry and drug design and discovery. It is widely found in diverse pharmacologically active substances and in some naturally-occurring compounds. Thiazole is a versatile building-block for lead generation, and is easily access of diverse derivatives for subsequent lead optimization. In the recent years, many thiazole derivatives have been synthesized and subjected to varied biological activities. In this article we intended to review the most important biological effects of thiazole-based compounds and highlight their roles in new leads identification and drug discovery. This article is also intended to help researches for finding potential future directions on the development of more potent and specific analogs of thiazole-based compounds for various biological targets.
Collapse
Affiliation(s)
- Adile Ayati
- Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran
| | - Saeed Emami
- Department of Medicinal Chemistry and Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
| | - Ali Asadipour
- Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medicinal Sciences, Kerman, Iran
| | - Abbas Shafiee
- Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran
| | - Alireza Foroumadi
- Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran; Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medicinal Sciences, Kerman, Iran.
| |
Collapse
|
27
|
de Azambuja Carvalho PH, Duval AR, Manzolli Leite FR, Nedel F, Cunico W, Lund RG. (7-Chloroquinolin-4-yl)arylhydrazones: Candida albicans enzymatic repression and cytotoxicity evaluation, Part 2. J Enzyme Inhib Med Chem 2015; 31:126-31. [PMID: 25807296 DOI: 10.3109/14756366.2015.1010527] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
OBJECTIVE This work describes the anti-enzymatic activity of (7-chloroquinolin-4-yl)arylhydrazones against Candida albicans and examines their cytotoxicity. MATERIAL AND METHODS Ten C. albicans strains [nine isolates and one azole-resistant standard strain (ATCC 62342)] were used to assess the anti-enzymatic activity. Fifteen compounds at sub-antifungal concentrations ranging from 12.5 to 100 µg/ml were assessed after a 30-min exposure. The strains were seeded onto petri dishes with selective agar media for aspartyl proteases (Saps) and phospholipases (PLs). Enzymatic inhibition was measured by the reduction of the precipitation zone (Pz) against untreated strains (positive control). A colorimetric MTT assay was used with 3T3/NIH mouse fibroblasts to evaluate cytotoxicity. Cells were exposed to 15 compounds in concentrations from 6.25 to 100 µg/ml for 24 and 48 h. RESULTS Four hydrazones showed enzymatic repression values over 40% to Pl and three over 20% to Saps. The cell viability was over 50% at hydrazone concentrations of 25-100 µg/ml. CONCLUSION These results revealed that select (7-chloroquinolin-4-yl)arylhydrazones may be potential antifungal agents for the control of C. albicans infections.
Collapse
Affiliation(s)
| | - Auri Rocha Duval
- b LaQuiABio - Laboratory of Bioactive Applied Chemistry , Center of Chemical, Pharmaceutical and Food Sciences (CCQFA), Federal University of Pelotas , Pelotas , RS , Brazil
| | - Fabio Renato Manzolli Leite
- c Clinics and Semiology Department , Pelotas Dental School, Federal University of Pelotas , Pelotas , RS , Brazil
| | - Fernanda Nedel
- d Cell and Tissue Biology Nucleus (NCTBio), Post-Graduate Program in Dentistry, Pelotas Dental School, Federal University of Pelotas , Pelotas , RS , Brazil .,e Post-Graduate Program in Health and Behavior, Catholic University of Pelotas , Pelotas , RS , Brazil , and
| | - Wilson Cunico
- b LaQuiABio - Laboratory of Bioactive Applied Chemistry , Center of Chemical, Pharmaceutical and Food Sciences (CCQFA), Federal University of Pelotas , Pelotas , RS , Brazil
| | - Rafael Guerra Lund
- f Post-Graduate Program in Dentistry, Pelotas Dental School, Federal University of Pelotas , Rio Grande do Sul , Brazil
| |
Collapse
|
28
|
D’Ascenzio M, Chimenti P, Gidaro MC, De Monte C, De Vita D, Granese A, Scipione L, Di Santo R, Costa G, Alcaro S, Yáñez M, Carradori S. (Thiazol-2-yl)hydrazone derivatives from acetylpyridines as dual inhibitors of MAO and AChE: synthesis, biological evaluation and molecular modeling studies. J Enzyme Inhib Med Chem 2015; 30:908-19. [DOI: 10.3109/14756366.2014.987138] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022] Open
Affiliation(s)
- Melissa D’Ascenzio
- Department of Drug Chemistry and Technologies, Sapienza University of Rome, Rome, Italy,
| | - Paola Chimenti
- Department of Drug Chemistry and Technologies, Sapienza University of Rome, Rome, Italy,
| | | | - Celeste De Monte
- Department of Drug Chemistry and Technologies, Sapienza University of Rome, Rome, Italy,
| | - Daniela De Vita
- Department of Drug Chemistry and Technologies, Sapienza University of Rome, Rome, Italy,
| | - Arianna Granese
- Department of Drug Chemistry and Technologies, Sapienza University of Rome, Rome, Italy,
| | - Luigi Scipione
- Department of Drug Chemistry and Technologies, Sapienza University of Rome, Rome, Italy,
| | - Roberto Di Santo
- Department of Drug Chemistry and Technologies, Sapienza University of Rome, Rome, Italy,
| | - Giosuè Costa
- Dipartimento di Scienze della Salute, Università di Catanzaro, Catanzaro, Italy,
| | - Stefano Alcaro
- Dipartimento di Scienze della Salute, Università di Catanzaro, Catanzaro, Italy,
| | - Matilde Yáñez
- University of Santiago de Compostela, Santiago de Compostela, Spain, and
| | - Simone Carradori
- Department of Pharmacy, “G. D'Annunzio“ University of Chieti-Pescara, Chieti Scalo (CH), Italy
| |
Collapse
|
29
|
Synthesis, cytotoxicity and molecular modelling studies of new phenylcinnamide derivatives as potent inhibitors of cholinesterases. Eur J Med Chem 2014; 78:43-53. [DOI: 10.1016/j.ejmech.2014.03.015] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2013] [Revised: 02/15/2014] [Accepted: 03/06/2014] [Indexed: 11/18/2022]
|